NuChem Sciences Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 300

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 3

NuChem Sciences General Information

Description

Provider of contract research services intended for the pharmaceutical and biotechnology industry. The company's services specialize in the field of medicinal chemistry, drug discovery biology, fragment screening, structure-activity-relationship design and computational drug design, thereby providing customers with relevant data to move their projects forward quickly and efficiently.

Contact Information

Formerly Known As
NuChem Therapeutics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 2350 rue Cohen
  • Suite 201
  • Saint-Laurent, Quebec H4R 2N6
  • Canada
+1 (514) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NuChem Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NuChem Sciences‘s full profile, request access.

Request a free trial

NuChem Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract research services intended for the pharmaceutical and biotechnology industry. The company's service
BPO/Outsource Services
Saint-Laurent, Canada
300 As of 2023
0000
000000000000 0000

000000

odo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000000000000 000000
Loughborough, United Kingdom
00 As of 0000
000000000000

000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000000000000 000000
Markham, Canada
000 As of 0000
00.00
000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuChem Sciences Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charnwood Molecular Private Equity-Backed Loughborough, United Kingdom 00 000000000000
Everest Clinical Research Private Equity-Backed Markham, Canada 000 00.00 000000000 00.00
Symeres Private Equity-Backed Groningen, Netherlands 000 000000000000
Resolian Private Equity-Backed Malvern, PA 000 000000000000
Atlant Clinical Corporate Backed or Acquired Moscow, Russia 000 000000&0
You’re viewing 5 of 21 competitors. Get the full list »

NuChem Sciences Patents

NuChem Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230322797-A1 Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds Pending 07-Apr-2022 0000000000
US-11608344-B2 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Active 04-May-2020 000000000 00
US-20230002390-A1 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Active 04-May-2020 000000000
US-11912711-B2 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Active 04-May-2020 0000000000 00
US-11884675-B2 Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use Active 04-May-2020 C07D487/04 00
To view NuChem Sciences’s complete patent history, request access »

NuChem Sciences Executive Team (7)

Name Title Board Seat Contact Info
Marc LeBel President, Chief Executive Officer & Chairman
Patrick Montpetit Chief Financial Officer & Partner
Daniel Guay Ph.D Co-Founder, Partner, Chief Scientific Officer, Executive Vice President & Board Member
John Mancuso Ph.D Partner & Director, Chemistry
Marc Janes Ph.D Partner, Vice President of Business Development and Innovation & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

NuChem Sciences Board Members (10)

Name Representing Role Since
000000 0000 00.0 NuChem Sciences Co-Founder, Partner, Chief Scientific Officer, Executive Vice President & Board Member 000 0000
000000 000000 Fonds de solidarite FTQ Board Observer 000 0000
0000 00000 00.0 NuChem Sciences Partner, Vice President of Business Development and Innovation & Board Member 000 0000
0000 00000 NuChem Sciences President, Chief Executive Officer & Chairman 000 0000
000000 0000000 Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

NuChem Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuChem Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NuChem Sciences‘s full profile, request access.

Request a free trial

NuChem Sciences Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IniXium 31-Oct-2022 0000000000 BPO/Outsource Services 0000 0000
OmegaChem 17-Aug-2021 0000000000 000.00 Drug Discovery 0000 0000
Amplia Pharmatek 31-Oct-2019 Buyout/LBO Drug Discovery 0000 0000
To view NuChem Sciences’s complete investments history, request access »

NuChem Sciences Subsidiaries (3)

Company Name Industry Location Founded
IniXium BPO/Outsource Services Laval, Canada 2014
Amplia Pharmatek Drug Discovery Montreal, Canada 0000
OmegaChem Drug Discovery Levis, Canada 0000
To view NuChem Sciences’s complete subsidiaries history, request access »

NuChem Sciences FAQs

  • When was NuChem Sciences founded?

    NuChem Sciences was founded in 2011.

  • Who is the founder of NuChem Sciences?

    Daniel Guay Ph.D is the founder of NuChem Sciences.

  • Where is NuChem Sciences headquartered?

    NuChem Sciences is headquartered in Saint-Laurent, Canada.

  • What is the size of NuChem Sciences?

    NuChem Sciences has 300 total employees.

  • What industry is NuChem Sciences in?

    NuChem Sciences’s primary industry is BPO/Outsource Services.

  • Is NuChem Sciences a private or public company?

    NuChem Sciences is a Private company.

  • What is NuChem Sciences’s current revenue?

    The current revenue for NuChem Sciences is 000000.

  • How much funding has NuChem Sciences raised over time?

    NuChem Sciences has raised $30M.

  • Who are NuChem Sciences’s investors?

    AmorChem, BDC Capital, Fonds de solidarite FTQ, GeneChem, and Institut De Recherche Clinique De Montreal are 5 of 8 investors who have invested in NuChem Sciences.

  • Who are NuChem Sciences’s competitors?

    Charnwood Molecular, Everest Clinical Research, Symeres, Resolian, and Atlant Clinical are some of the 21 competitors of NuChem Sciences.

  • When was NuChem Sciences acquired?

    NuChem Sciences was acquired on 31-Jul-2023.

  • Who acquired NuChem Sciences?

    NuChem Sciences was acquired by Sygnature Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »